Literature DB >> 10650300

Primary and subsequent coronary risk appraisal: new results from the Framingham study.

R B D'Agostino1, M W Russell, D M Huse, R C Ellison, H Silbershatz, P W Wilson, S C Hartz.   

Abstract

BACKGROUND: Coronary heart disease continues to be one of the most common chronic illnesses in the United States and most of the developed world. Clinicians and health authorities have interest in identifying individuals at increased risk of CHD. The Framingham Heart Study has over the years produced mathematical "health risk appraisal models" that relate risk factors to the probability of developing CHD. METHODS AND
RESULTS: New sex-specific models from The Framingham Heart Study for primary and secondary (subsequent) CHD have been produced. The primary CHD models are appropriate for assessing CHD risk in persons free of cardiovascular disease and contain risk factors such as triglyceride levels, alcohol use, and menopausal status, risk factors not included in previously published models. The subsequent CHD models are applicable for persons with a history of CHD or ischemic stroke who have survived the acute period after the event. Age, blood lipid levels (total cholesterol and HDL cholesterol), and diabetes status are significant for men and women. In addition, systolic blood pressure and cigarette smoking are significant predictors of subsequent CHD in women.
CONCLUSIONS: These new models are useful tools for better understanding the relation between risk factors and the occurrences of CHD events in individuals who are free of cardiovascular disease as well as persons who have had a prior CHD event or stroke. With the development of these latter models, the importance of blood lipid levels, diabetes, and, in women, systolic blood pressure and cigarette smoking as independent predictors of risk is once again underscored.

Entities:  

Mesh:

Year:  2000        PMID: 10650300     DOI: 10.1067/mhj.2000.96469

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  122 in total

1.  New heart risk equations do not affect existing guidelines.

Authors:  Richard Milne
Journal:  BMJ       Date:  2002-11-02

2.  Analysis of predicted coronary heart disease risk in England based on Framingham study risk appraisal models published in 1991 and 2000.

Authors:  Kiran Nanchahal; John R Duncan; Paul N Durrington; Rodney T Jackson
Journal:  BMJ       Date:  2002-07-27

Review 3.  Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.

Authors:  Alberto Ortiz; Ziad A Massy; Danilo Fliser; Bengt Lindholm; Andrzej Wiecek; Alberto Martínez-Castelao; Adrian Covic; David Goldsmith; Gültekin Süleymanlar; Gérard M London; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

4.  Cardiovascular disease prevention: a basic but evolving goal for medicine.

Authors:  Douglas B Bogart
Journal:  Mo Med       Date:  2011 Nov-Dec

5.  Access to cardiac interventional services in Alabama and Mississippi: a geographical information system analysis.

Authors:  Barbara Ann Graves
Journal:  Perspect Health Inf Manag       Date:  2010-04-01

6.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Authors:  B R Hemmelgarn; Finlay A McAlister; Steven Grover; Martin G Myers; Donald W McKay; Peter Bolli; Carl Abbott; Ernesto L Schiffrin; George Honos; Ellen Burgess; Karen Mann; Thomas Wilson; Brian Penner; Guy Tremblay; Alain Milot; Arun Chockalingam; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

7.  Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.

Authors:  John R Cook; Don Yin; Evo Alemao; Glenn Davies; Karl J Krobot; Enrico Veltri; Leslie Lipka; Xavier Badia
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 8.  The role of global risk assessment in hypertension therapy.

Authors:  S A Grover; Brenda Hemmelgarn; Lawrence Joseph; Alain Milot; Guy Tremblay
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

9.  Sex differences in intracerebral hemorrhage expansion and mortality.

Authors:  Sandro Marini; Andrea Morotti; Alison M Ayres; Katherine Crawford; Christina E Kourkoulis; Umme K Lena; Edip M Gurol; Anand Viswanathan; Joshua N Goldstein; Steven M Greenberg; Alessandro Biffi; Jonathan Rosand; Christopher D Anderson
Journal:  J Neurol Sci       Date:  2017-05-31       Impact factor: 3.181

10.  Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis.

Authors:  Nick Bansback; Roberta Ara; Sue Ward; Aslam Anis; Hyon K Choi
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.